TT Capital Management’s CVS Health CVS Stock Holding History

TT Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	-$4.49K	–	74
2024 Q4	$4.49K	Buy	+100	New	+$5.61K	﹤0.01%	77

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TT Capital Management's CVS Position: Q1 2026 in Review

TT Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,784 shares — an estimated $221K sold.

TT Capital Management first reported a position in CVS in Q4 2024 and held it in 5 quarters. The position peaked at $283K in Q2 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

TT Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
TT Capital Management sold 2,784 CVS Health shares in Q1 2026, an estimated $221K.
TT Capital Management first reported a position in CVS Health in Q4 2024 and held it in 5 quarters.
TT Capital Management's CVS Health position peaked at $283K in Q2 2025.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on TT Capital Management's 13F filing for Q1 2026, filed 12 May 2026.